Sven-Ulrik Gorr

9PUBLICATIONS
2CO-AUTHORS
Microbial geneticsMedical devicesProteins and peptidesMedical infection agents (incl. prions)Periodontics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 17, 2026
Erratum for Gorr, "Resisting the resistance: the antimicrobial peptide DGL13K selects for small colony variants of Staphylococcus aureus that show increased resistance to its stereoisomer LGL13K, but not to DGL13K".

Sven-Ulrik Gorr

|Jan 28, 2026
Correction: Gorr, S.-U. Targeted Modification of the Antimicrobial Peptide DGL13K Reveals a Naturally Optimized Sequence for Topical Applications. Microorganisms 2025, 13, 2355.

Sven-Ulrik Gorr

|Oct 29, 2025
Targeted Modification of the Antimicrobial Peptide DGL13K Reveals a Naturally Optimized Sequence for Topical Applications.

Sven-Ulrik Gorr

|Jun 04, 2025
Resisting the resistance: the antimicrobial peptide DGL13K selects for small colony variants of Staphylococcus aureus that show increased resistance to its stereoisomer LGL13K, but not to DGL13K.

Sven-Ulrik Gorr

|Oct 24, 2024
The oral pathogen Porphyromonas gingivalis gains tolerance to the antimicrobial peptide DGL13K by synonymous mutations in hagA.

Sven-Ulrik Gorr, Ruoqiong Chen, Juan E Abrahante

|Aug 25, 2022
The antimicrobial peptide DGL13K is active against drug-resistant gram-negative bacteria and sub-inhibitory concentrations stimulate bacterial growth without causing resistance.

Sven-Ulrik Gorr, Hunter V Brigman, Jadyn C Anderson

Pageof 2

Frequent Collaborators

1 joint publications

Jeffrey W Hall

1 joint publications

Juan E Abrahante